BMO Capital analyst Keith Bachman lowered the firm’s price target on IBM to $145 from $155 and keeps a Market Perform rating on the shares. The company’s Q1 results were "mixed but reasonable" given the low expectations, the analyst tells investors in a research note. The firm "remains skeptical" however that IBM can grow Software and believes that margin challenges will persist.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IBM:
- IBM price target lowered to $140 from $150 at Evercore ISI
- IBM price target lowered to $140 from $150 at Stifel
- IBM price target lowered to $135 from $143 at Morgan Stanley
- Moderna, IBM to explore quantum computing, generative AI for mRNA science
- IBM says expects $2B in run rate savings by 2024 from cost saving initiatives
